Ethan D. Leder
Co-Founder, Partner & Executive Chairman
Description:
Ethan Leder is the Co-Founder and Executive Chairman of Precision Medicine Group. Over the past 25 years, he has been an entrepreneur focused on building and managing innovative, market-leading companies that address critical gaps in the healthcare industry. Prior to Precision Medicine Group, Leder was the Founder and CEO of United BioSource Corporation (UBC), which became the leader in real-world research addressing safety, value, and comparative effectiveness for the life science industry. UBC was acquired by Medco Health Solutions in late 2010 and is now part of Express Scripts. Before UBC, Ethan was the Co-Founder and CEO of U.S. Bioservices, Inc., which addressed a growing need for personalized, direct-to-patient distribution of high-cost biotechnology for serious medical conditions. U.S. Bioservices was acquired by AmerisourceBergen in 2002. Prior to U.S. Bioservices, he was the Founder and President of HealthCare Financial Partners, the leading specialty lender to the healthcare industry. It was acquired by GE Capital in late 1999. Ethan received his undergraduate degree from Johns Hopkins University and his Juris Doctor from Georgetown University Law Center. He also serves on the Board of Trustees of Johns Hopkins University and is active in many charitable and community development projects in the Washington DC, metropolitan area.
Summary:
Ethan Leder is the Co-Founder and Executive Chairman of Precision Medicine Group. Over the past 25 years, he has been an entrepreneur focuse...
Number of Registered Investments:1
Contact Details:
- Address: Washington, District of Columbia, United States
- No email is provided
Location:Washington, District of Columbia, United States
Email is Not Provided
Phone Number:Washington, District of Columbia, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 